StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
IBIS-M.TA$4760.00-0.21%
Fair $4760.00+0.0%

IBIS-M.TA

IBIS-M.TA

Financial Services / Asset ManagementTel Aviv

$4760.00

-10.00 (-0.21%)

Fairly Valued+0.0%Fair Value $4760.00Fund rank 27/100 · Data gapFallback financials|
SA 45/C
F-Score: 2/9
Low Profitability

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 100.0/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 12/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

45/100

C

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. ROE is 1.4%, below the 5% threshold
Thesis & Journal · IBIS-M.TALocal privado en este navegador · IBIS-M.TA
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$17M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

142.6%

↑

Gross Margin

-9.0%

↓

Debt/Equity

-0.37

↓
52-Week Range$4760
$685$4858

TradingView lightweight chart

IBIS-M.TA price, volumen y niveles de valoración

Último $4,760Periodo -99.9%
Fair value: $4,760

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+31.1%

FCF CAGR

—

FCF margin

-170.7%

FCF / Net income

0.24x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.4M · net income $-10.1M · FCF $-2.5M

2022-FY → 2025-FY

Gross margin

-9.0%+340.7% pts

Operating margin

-651.0%+3946.2% pts

Net margin

-696.9%+4266.1% pts

FCF margin

-170.7%+1362.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.4M$1.4M$5.1M$2.9M$644000.00
Net Income$-10.1M$-10.1M$-8.8M$-6.2M$-32.0M
EBITDA$-9.4M$-9.4M$-7.8M$-5.2M$-31.6M
EPS——-32.90-35.10-21.40
Gross Margin-9.0%-9.0%68.3%31.5%-349.7%
Operating Margin-651.0%-651.0%-162.0%-198.1%-4597.2%
Net Margin-696.9%-696.9%-174.3%-214.3%-4963.0%
Balance Sheet
Debt/Equity-0.37-0.370.91-0.78-0.55
Current Ratio0.230.23———
Cash Flow
Free Cash Flow$-2.5M$-2.5M$-4.8M$-4.0M$-9.9M
Returns
ROE142.6%142.6%-1370.2%109.5%1420.5%
Valuation
P/B——2457.28——
Growth & Yield
Revenue Growth-71.4%-71.4%75.9%347.7%—
EPS Growth——6.3%-64.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +20.6%

Total return

+20.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-32.90 → n/d

Residual

+20.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+20.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.